r-n-jРоссийский неврологический журналRussian neurological journal2658-79472686-7192МИА10.30629/2658-7947-2023-28-4-60-67r-n-j-456Research ArticleКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ И НАБЛЮДЕНИЯCLINICAL RESEARCH AND SURVEILLANCEАутоиммунный анти-NMDA-энцефалит, ассоциированный с новой коронавирусной инфекцией COVID-19Autoimmune аnti-NMDA encephalitis associated with the new coronavirus infection COVID-19ПанченкоН. И.PanchenkoN. I.

 Панченко Никита Игоревич

Санкт-Петербург

 Saint Petersburg

tumblerspb@gmail.comhttps://orcid.org/0000-0002-1880-3122ШулешоваН. В.ShuleshovaN. V.

 Санкт-Петербург

 Saint Petersburg

https://orcid.org/0000-0001-5101-1007РуденкоД. И.RudenkoD. I.

 Санкт-Петербург

Saint Petersburg

https://orcid.org/0000-0001-5379-2863СкулябинД. И.SkulyabinD. I.

 Санкт-Петербург

 Saint Petersburg

https://orcid.org/0000-0002-9108-2317КолчевС. А.KolchevS. A.

Санкт-Петербург

 Saint Petersburg

https://orcid.org/0000-0003-0975-6608ПерфильевС. В.PerfilevS. V.

 Санкт-Петербург

Saint Petersburg

https://orcid.org/0000-0002-4998-3699ЛапинС. В.LapinS. V.

Санкт-Петербург

 Saint Petersburg

Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова; Городская многопрофильная больница № 2РоссияI.P. Pavlov First Saint Petersburg State Medical University; Saint Petersburg State Multidisciplinary Hospital № 2Russian FederationПервый Санкт-Петербургский государственный медицинский университет им. акад. И.П. ПавловаРоссияI.P. Pavlov First Saint Petersburg State Medical UniversityRussian FederationВоенно-медицинская академия им. С.М. КироваРоссияS.M. Kirov Military Medical AcademyRussian FederationПсихиатрическая больница № 3 им. И.И. Скворцова-Степанова, Санкт-Петербург; Северо-Западный государственный медицинский университет им. И.И. МечниковаРоссияI.I. Skvortsov-Stepanov St. Petersburg Psychiatric Hospital № 3; I.I. Mechnikov North-Western State Medical UniversityRussian FederationГородская многопрофильная больница № 2РоссияSaint Petersburg State Multidisciplinary Hospital № 2Russian Federation2023021020232846067Copyright © Панченко Н.И., Шулешова Н.В., Руденко Д.И., Скулябин Д.И., Колчев С.А., Перфильев С.В., Лапин С.В., 20232023Панченко Н.И., Шулешова Н.В., Руденко Д.И., Скулябин Д.И., Колчев С.А., Перфильев С.В., Лапин С.В.Panchenko N.I., Shuleshova N.V., Rudenko D.I., Skulyabin D.I., Kolchev S.A., Perfilev S.V., Lapin S.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.r-n-j.com/jour/article/view/456

В статье представлен клинический случай 19-летней пациентки с достоверным аутоиммунным анти-NMDА-энцефалитом на фоне перенесенной коронавирусной инфекции, который сопровождался в дебюте заболевания симптомами кататонии, эпилептическим синдромом и мутизмом. Этот случай дополняет статистику наблюдений данной патологии включением вируса SARS-CоV-2 в список возможных этиологических факторов. Проведен анализ симптомов кататонии, доминирующей в дебюте клинической картины заболевания.

The article presents a clinical case of a 19-year-old patient with reliable autoimmune anti-NMDA encephalitis, developed after a coronavirus infection, which was accompanied by the signs of catatonia, epilepsy and mutism at the onset of the disease. This case enlarges the statistics of observations of this pathology by including the SARS-COV 2 virus to the list of possible etiological factors. The analysis of the catatonia signs, dominating at the onset of the disease, was carried out.

аутоиммунный анти-NMDА-энцефалиткоронавирусная инфекция COVID-19эпилептический синдромкататониямутизм.autoimmune anti-NMDA encephalitiscoronavirus infection COVID-19epileptic syndromecatatoniamutismus.ReferencesKolls B.J., O’Keefe Y.A., Sahgal A.K. Autoimmune Encephalitis: NMDA Receptor Encephalitis as an Example of Translational Neuroscience. Neurotherapeutics. 2020;17(2):404–413. https://doi.org/10.1007/s13311-020-00861-2Kolls B.J., O’Keefe Y.A., Sahgal A.K. Autoimmune Encephalitis: NMDA Receptor Encephalitis as an Example of Translational Neuroscience. Neurotherapeutics. 2020;17(2):404–413. https://doi.org/10.1007/s13311-020-00861-2Dalmau J., Armangué T., Planagumà J., Radosevic M., Mannara F., Leypoldt F. et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. The Lancet Neurology. 2019;18(11):1045–1057. https://doi.org/10.1016/S1474-4422(19)30244-3Dalmau J., Armangué T., Planagumà J., Radosevic M., Mannara F., Leypoldt F. et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. The Lancet Neurology. 2019;18(11):1045–1057. https://doi.org/10.1016/S1474-4422(19)30244-3Schmitt S.E., Pargeon K., Frechette E.S., Hirsch L.J., Dalmau J., Friedman D. Extreme delta brush; A unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79(11):1094–1100. https://doi.org/10.1212/WNL.0b013e3182698cd8Schmitt S.E., Pargeon K., Frechette E.S., Hirsch L.J., Dalmau J., Friedman D. Extreme delta brush; A unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012;79(11):1094–1100. https://doi.org/10.1212/WNL.0b013e3182698cd8Vitaliani R., Mason W., Ances B., Zwerdling T., Jiang Z., Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Annals of Neurology. 2005;58(4):594–604. https://doi.org/10.1002/ana.20614Vitaliani R., Mason W., Ances B., Zwerdling T., Jiang Z., Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Annals of Neurology. 2005;58(4):594–604. https://doi.org/10.1002/ana.20614Dalmau J., Tüzün E., Wu H., Masjuan J., Rossi J.E., Voloschin A. et al. Paraneoplastic anti–N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology. 2007;61(1):25–36. https://doi.org/https://doi.org/10.1002/ana.21050Dalmau J., Tüzün E., Wu H., Masjuan J., Rossi J.E., Voloschin A. et al. Paraneoplastic anti–N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology. 2007;61(1):25–36. https://doi.org/https://doi.org/10.1002/ana.21050Armangue T., Leypoldt F., Dalmau, J. Autoimmune encephalitis as diff erential diagnosis of infectious encephalitis. Current Opinion in Neurology. 2014;27(3):361–368. https://doi.org/10.1097/WCO.0000000000000087Armangue T., Leypoldt F., Dalmau, J. Autoimmune encephalitis as diff erential diagnosis of infectious encephalitis. Current Opinion in Neurology. 2014;27(3):361–368. https://doi.org/10.1097/WCO.0000000000000087Huang Q., Xie Y., Hu Z., Tang X. Anti-N-methyl-D-aspartate receptor encephalitis: A review of pathogenic mechanisms, treatment, prognosis. Brain Research. 2020;1727(June2019):146549. https://doi.org/10.1016/j.brainres.2019.146549Huang Q., Xie Y., Hu Z., Tang X. Anti-N-methyl-D-aspartate receptor encephalitis: A review of pathogenic mechanisms, treatment, prognosis. Brain Research. 2020;1727(June2019):146549. https://doi.org/10.1016/j.brainres.2019.146549Valencia Sanchez C., Theel E., Binnicker M., Toledano M., McKeon A. Autoimmune Encephalitis After SARS-CoV-2 Infection. Neurology. 2021;97(23):e2262 LP–e2268. https://doi.org/10.1212/WNL.0000000000012931Valencia Sanchez C., Theel E., Binnicker M., Toledano M., McKeon A. Autoimmune Encephalitis After SARS-CoV-2 Infection. Neurology. 2021;97(23):e2262 LP–e2268. https://doi.org/10.1212/WNL.0000000000012931Хорева М.А., Серикова И.Ю., Смагина И.В., Голенко А.А., Смирнов К.В., Завьялов А.Е., Драганик И.А. Клинический случай энцефалита с антителами к NMDA-рецепторам на фоне новой коронавирусной инфекции (COVID-19). Российский неврологический журнал. 2022;27(1):106–112. [Khoreva M.A., Serikova I.Y., Smagina I.V., Golenko A.A., Smirnov K.V., Zavyalov A.E., Draganic I.A. Clinical case of anti-NMDA receptor encephalitis associated with new coronaviral infection (COVID-19). Russian neurological journal. 2022;27(1):106–112. (In Russ.)]. https://doi.org/10.30629/2658-7947-2022-27-1-106-112Хорева М.А., Серикова И.Ю., Смагина И.В., Голенко А.А., Смирнов К.В., Завьялов А.Е., Драганик И.А. Клинический случай энцефалита с антителами к NMDA-рецепторам на фоне новой коронавирусной инфекции (COVID-19). Российский неврологический журнал. 2022;27(1):106–112. [Khoreva M.A., Serikova I.Y., Smagina I.V., Golenko A.A., Smirnov K.V., Zavyalov A.E., Draganic I.A. Clinical case of anti-NMDA receptor encephalitis associated with new coronaviral infection (COVID-19). Russian neurological journal. 2022;27(1):106–112. (In Russ.)]. https://doi.org/10.30629/2658-7947-2022-27-1-106-112Gouse B.M., Spears W.E., Nieves Archibald A., Montalvo C. Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism. Brain Behav Immun. 2020;89:529–530. https://doi.org/10.1016/j.bbi.2020.08.007Gouse B.M., Spears W.E., Nieves Archibald A., Montalvo C. Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism. Brain Behav Immun. 2020;89:529–530. https://doi.org/10.1016/j.bbi.2020.08.007Vazquez-Guevara D., Badial-Ochoa S., Caceres-Rajo K.M., Rodriguez-Leyva I. Catatonic syndrome as the presentation of encephalitis in association with COVID-19. BMJ Case Rep. 2021;14(6):e240550. https://doi.org/10.1136/bcr-2020-240550Vazquez-Guevara D., Badial-Ochoa S., Caceres-Rajo K.M., Rodriguez-Leyva I. Catatonic syndrome as the presentation of encephalitis in association with COVID-19. BMJ Case Rep. 2021;14(6):e240550. https://doi.org/10.1136/bcr-2020-240550Fusunyan M., Praschan N., Fricchione G., Beach S. Akinetic Mutism and Coronavirus Disease 2019: A Narrative Review. J Acad Consult Liaison Psychiatry. 2021;62(6):625–633. https://doi.org/10.1016/j.jaclp.2021.08.009Fusunyan M., Praschan N., Fricchione G., Beach S. Akinetic Mutism and Coronavirus Disease 2019: A Narrative Review. J Acad Consult Liaison Psychiatry. 2021;62(6):625–633. https://doi.org/10.1016/j.jaclp.2021.08.009Pollak T.A., Lennox B.R., Müller S., Benros M.E., Prüss H., Tebartz van Elst L. et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. The Lancet Psychiatry. 2020;7(1):93–108. https://doi.org/10.1016/S2215-0366(19)30290-1Pollak T.A., Lennox B.R., Müller S., Benros M.E., Prüss H., Tebartz van Elst L. et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. The Lancet Psychiatry. 2020;7(1):93–108. https://doi.org/10.1016/S2215-0366(19)30290-1Blum R.A., Tomlinson A.R., Jetté N., Kwon C.S., Easton A., Yeshokumar A. K. Assessment of long-term psychosocial outcomes in anti-NMDA receptor encephalitis. Epilepsy and Behavior. 2020;108:107088. https://doi.org/10.1016/j.yebeh.2020.107088Blum R.A., Tomlinson A.R., Jetté N., Kwon C.S., Easton A., Yeshokumar A. K. Assessment of long-term psychosocial outcomes in anti-NMDA receptor encephalitis. Epilepsy and Behavior. 2020;108:107088. https://doi.org/10.1016/j.yebeh.2020.107088Al-Diwani A., Handel A., Townsend L., Pollak T., Leite M. I., Harrison P.J. et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. The Lancet Psychiatry. 2019;6(3):235–246. https://doi.org/10.1016/S2215-0366(19)30001-XAl-Diwani A., Handel A., Townsend L., Pollak T., Leite M. I., Harrison P.J. et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. The Lancet Psychiatry. 2019;6(3):235–246. https://doi.org/10.1016/S2215-0366(19)30001-XGraus F., Titulaer M.J., Balu R., Benseler S., Bien C. G., Cellucci T. et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology. 2016;15(4):391–404. https://doi.org/10.1016/S1474-4422(15)00401-9Graus F., Titulaer M.J., Balu R., Benseler S., Bien C. G., Cellucci T. et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology. 2016;15(4):391–404. https://doi.org/10.1016/S1474-4422(15)00401-9Balu R., Mccracken L., Lancaster E., Graus F., Dalmau J., Titulaer M.J. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2019;92(3):E244–E252. https://doi.org/10.1212/WNL.0000000000006783Balu R., Mccracken L., Lancaster E., Graus F., Dalmau J., Titulaer M.J. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2019;92(3):E244–E252. https://doi.org/10.1212/WNL.0000000000006783Quinn T., Dawson J., Walters M. Dr John Rankin; His Life, Legacy and the 50th Anniversary of the Rankin Stroke Scale. Scottish Medical Journal. 2008;53(1):44–47. https://doi.org/10.1258/RSMSMJ.53.1.44Quinn T., Dawson J., Walters M. Dr John Rankin; His Life, Legacy and the 50th Anniversary of the Rankin Stroke Scale. Scottish Medical Journal. 2008;53(1):44–47. https://doi.org/10.1258/RSMSMJ.53.1.44Bush G., Fink M., Petrides G., Dowling F., Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica. 1996;93(2);129–136. https://doi.org/https://doi.org/10.1111/j.1600-0447.1996.tb09814.xBush G., Fink M., Petrides G., Dowling F., Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica. 1996;93(2);129–136. https://doi.org/https://doi.org/10.1111/j.1600-0447.1996.tb09814.xTandon R., Heckers S., Bustillo J., Barch D.M., Gaebel W., Gur R.E. et al. Catatonia in DSM-5. Schizophrenia Research. 2013;150(1):26–30. https://doi.org/10.1016/j.schres.2013.04.03Tandon R., Heckers S., Bustillo J., Barch D.M., Gaebel W., Gur R.E. et al. Catatonia in DSM-5. Schizophrenia Research. 2013;150(1):26–30. https://doi.org/10.1016/j.schres.2013.04.03Fraune J., Gerlach S., Rentzsch K., Teegen B., Lederer S., Affeldt K. et al. Multiparametric serological testing in autoimmune encephalitis using computer-aided immunofl uorescence microscopy (CAIFM). Autoimmunity Reviews. 2016;15(10):937–942. https://doi.org/10.1016/j.autrev.2016.07.024Fraune J., Gerlach S., Rentzsch K., Teegen B., Lederer S., Affeldt K. et al. Multiparametric serological testing in autoimmune encephalitis using computer-aided immunofl uorescence microscopy (CAIFM). Autoimmunity Reviews. 2016;15(10):937–942. https://doi.org/10.1016/j.autrev.2016.07.024Titulaer M.J., McCracken L., Gabilondo I., Armangué T., Glaser C., Iizuka T. et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet Neurology. 2013;12(2):157–165. https://doi.org/https://doi.org/10.1016/S1474-4422(12)70310-1Titulaer M.J., McCracken L., Gabilondo I., Armangué T., Glaser C., Iizuka T. et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet Neurology. 2013;12(2):157–165. https://doi.org/https://doi.org/10.1016/S1474-4422(12)70310-1Planagumà J., Haselmann H., Mannara F., Petit-Pedrol M., Grünewald B., Aguilar E. et al. Ephrin-B2 prevents N-methylD-aspartate receptor antibody eff ects on memory and neuroplasticity. Annals of Neurology. 2016;80(3):388–400. https://doi.org/https://doi.org/10.1002/ana.24721Planagumà J., Haselmann H., Mannara F., Petit-Pedrol M., Grünewald B., Aguilar E. et al. Ephrin-B2 prevents N-methylD-aspartate receptor antibody eff ects on memory and neuroplasticity. Annals of Neurology. 2016;80(3):388–400. https://doi.org/https://doi.org/10.1002/ana.24721Takahashi Y., Nishimura S., Takao E., Kasai R., Enokida K., Ida K. et al. Characteristics of internalization of NMDA-type GluRs with antibodies to GluN1 and GluN2B. Journal of Neuroimmunology. 2020;349:577427. https://doi.org/10.1016/j.jneuroim.2020.577427Takahashi Y., Nishimura S., Takao E., Kasai R., Enokida K., Ida K. et al. Characteristics of internalization of NMDA-type GluRs with antibodies to GluN1 and GluN2B. Journal of Neuroimmunology. 2020;349:577427. https://doi.org/10.1016/j.jneuroim.2020.577427Sell J., Haselmann H., Hallermann S., Hust M., Geis C. Autoimmune encephalitis: novel therapeutic targets at the preclinical level. Expert Opinion on Therapeutic Targets. 2021;25(1):37–47. https://doi.org/10.1080/14728222.2021.1856370Sell J., Haselmann H., Hallermann S., Hust M., Geis C. Autoimmune encephalitis: novel therapeutic targets at the preclinical level. Expert Opinion on Therapeutic Targets. 2021;25(1):37–47. https://doi.org/10.1080/14728222.2021.1856370Prüss H. Autoantibodies in neurological disease. Nature Reviews Immunology. 2021;21(12):798–813. https://doi.org/10.1038/s41577-021-00543-wPrüss H. Autoantibodies in neurological disease. Nature Reviews Immunology. 2021;21(12):798–813. https://doi.org/10.1038/s41577-021-00543-wDalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet Neurology. 2011;10(1):63–74. https://doi.org/https://doi.org/10.1016/S1474-4422(10)70253-2Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet Neurology. 2011;10(1):63–74. https://doi.org/https://doi.org/10.1016/S1474-4422(10)70253-2Mann A.P., Grebenciucova E., Lukas R.V. Anti-N-methyl-Daspartate-receptor encephalitis: Diagnosis, optimal management, and challenges. Therapeutics and Clinical Risk Managemen. 2014;10(1):517–524. https://doi.org/10.2147/TCRM.S61967Mann A.P., Grebenciucova E., Lukas R.V. Anti-N-methyl-Daspartate-receptor encephalitis: Diagnosis, optimal management, and challenges. Therapeutics and Clinical Risk Managemen. 2014;10(1):517–524. https://doi.org/10.2147/TCRM.S61967Ciano-Petersen N.L., Cabezudo-García P., Muñiz-Castrillo S., Honnorat J., Serrano-Castro P.J., Oliver-Martos B. Current status of biomarkers in anti-n-methyl-d-aspartate receptor encephalitis. International Journal of Molecular Sciences. 2021;22(23):1–16. https://doi.org/10.3390/ijms222313127Ciano-Petersen N.L., Cabezudo-García P., Muñiz-Castrillo S., Honnorat J., Serrano-Castro P.J., Oliver-Martos B. Current status of biomarkers in anti-n-methyl-d-aspartate receptor encephalitis. International Journal of Molecular Sciences. 2021;22(23):1–16. https://doi.org/10.3390/ijms222313127Derksen S.J., Goraj B., Molenaar J.P., Van der Hoeven J.G. Severe anti NMDA encephalitis and EBV infection. Netherlandes Journal of Critical Care. 2013;17(5):19–21.Derksen S.J., Goraj B., Molenaar J.P., Van der Hoeven J.G. Severe anti NMDA encephalitis and EBV infection. Netherlandes Journal of Critical Care. 2013;17(5):19–21.Solís N., Salazar L., Hasbun R. Anti-NMDA Receptor antibody encephalitis with concomitant detection of Varicella zoster virus. Journal of Clinical Virology. 2016;83:26–28. https://doi.org/10.1016/j.jcv.2016.08.292Solís N., Salazar L., Hasbun R. Anti-NMDA Receptor antibody encephalitis with concomitant detection of Varicella zoster virus. Journal of Clinical Virology. 2016;83:26–28. https://doi.org/10.1016/j.jcv.2016.08.292Onpoaree N., Veeravigrom M., Sanpavat A., Suratannon N., Sintusek P. Unremitting diarrhoea in a girl diagnosed anti-Nmethyl-D-aspartate-receptor encephalitis: A case report. World Journal of Clinical Cases. 2020;8(20):4866–4875. https://doi.org/10.12998/wjcc.v8.i20.4866Onpoaree N., Veeravigrom M., Sanpavat A., Suratannon N., Sintusek P. Unremitting diarrhoea in a girl diagnosed anti-Nmethyl-D-aspartate-receptor encephalitis: A case report. World Journal of Clinical Cases. 2020;8(20):4866–4875. https://doi.org/10.12998/wjcc.v8.i20.4866Gable M.S., Gavali S., Radner A., Tilley D.H., Lee B., Dyner L. et al. Anti-NMDA receptor encephalitis: Report of ten cases and comparison with viral encephalitis. European Journal of Clinical Microbiology and Infectious Diseases. 2009;28(12):1421–1429. https://doi.org/10.1007/s10096-009-0799-0Gable M.S., Gavali S., Radner A., Tilley D.H., Lee B., Dyner L. et al. Anti-NMDA receptor encephalitis: Report of ten cases and comparison with viral encephalitis. European Journal of Clinical Microbiology and Infectious Diseases. 2009;28(12):1421–1429. https://doi.org/10.1007/s10096-009-0799-0Nóbrega P.R., Morais N.M. de M., Braga-Neto P., da Silva Barros L.S., Honório F.P.P., Dellavance A. et al. NMDAR Encephalitis Associated With Acute Chikungunya Virus Infection:A New Trigger? Frontiers in Pediatrics. 2020;8(April):8–11. https://doi.org/10.3389/fped.2020.00176Nóbrega P.R., Morais N.M. de M., Braga-Neto P., da Silva Barros L.S., Honório F.P.P., Dellavance A. et al. NMDAR Encephalitis Associated With Acute Chikungunya Virus Infection:A New Trigger? Frontiers in Pediatrics. 2020;8(April):8–11. https://doi.org/10.3389/fped.2020.00176Martinez H.R., Olguin-Ramirez L.A., Camara-Lemarroy C.R. Lyme borreliosis as a trigger for NMDA receptor encephalitis? Neurological Sciences. 2018;39(10):1815–1817. https://doi.org/10.1007/s10072-018-3497-9Martinez H.R., Olguin-Ramirez L.A., Camara-Lemarroy C.R. Lyme borreliosis as a trigger for NMDA receptor encephalitis? Neurological Sciences. 2018;39(10):1815–1817. https://doi.org/10.1007/s10072-018-3497-9Predkele N., Mednieks J. Lyme disease and associated nmdar encephalitis: A case report and literature review. Neurology International. 2021;13(4):487–496. https://doi.org/10.3390/neurolint13040048Predkele N., Mednieks J. Lyme disease and associated nmdar encephalitis: A case report and literature review. Neurology International. 2021;13(4):487–496. https://doi.org/10.3390/neurolint13040048Salovin A., Glanzman J., Roslin K., Armangue T., Lynch D.R., Panzer J.A. Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection. Neurology: Neuroimmunology and NeuroIn fl ammation. 2018;5(4):4–9. https://doi.org/10.1212/NXI.0000000000000458Salovin A., Glanzman J., Roslin K., Armangue T., Lynch D.R., Panzer J.A. Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection. Neurology: Neuroimmunology and NeuroIn fl ammation. 2018;5(4):4–9. https://doi.org/10.1212/NXI.0000000000000458Kim T.J., Lee S.T., Moon J., Sunwoo J.S., Byun J.I., Lim J.A. et al. Anti-LGI1 encephalitis is associated with unique HLA subtypes. Annals of Neurology. 2017;81(2):183–192. https://doi.org/10.1002/ana.24860Kim T.J., Lee S.T., Moon J., Sunwoo J.S., Byun J.I., Lim J.A. et al. Anti-LGI1 encephalitis is associated with unique HLA subtypes. Annals of Neurology. 2017;81(2):183–192. https://doi.org/10.1002/ana.24860Shu Y., Guo J., Ma X., Yan Y., Wang Y., Chen C. et al. Anti-Nmethyl-D-aspartate receptor (NMDAR) encephalitis is associated with IRF7, BANK1 and TBX21 polymorphisms in two populations. European Journal of Neurology. 2021;28(2):595–601. https://doi.org/10.1111/ene.14596Shu Y., Guo J., Ma X., Yan Y., Wang Y., Chen C. et al. Anti-Nmethyl-D-aspartate receptor (NMDAR) encephalitis is associated with IRF7, BANK1 and TBX21 polymorphisms in two populations. European Journal of Neurology. 2021;28(2):595–601. https://doi.org/10.1111/ene.14596Wenke N.K., Kreye J., Andrzejak E., van Casteren A., Leubner J., Murgueitio M.S. et al. N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit. Annals of Neurology. 2019;85(5):771–776. https://doi.org/10.1002/ana.25460Wenke N.K., Kreye J., Andrzejak E., van Casteren A., Leubner J., Murgueitio M.S. et al. N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit. Annals of Neurology. 2019;85(5):771–776. https://doi.org/10.1002/ana.25460Ding Y., Yang C., Zhou Z., Peng Y., Chen J., Pan S. et al. Clinical signifi cance of soluble adhesion molecules in anti-NMDAR encephalitis patients. Annals of Clinical and Translational Neurology. 2019;6(5):945–953. https://doi.org/10.1002/acn3.740Ding Y., Yang C., Zhou Z., Peng Y., Chen J., Pan S. et al. Clinical signifi cance of soluble adhesion molecules in anti-NMDAR encephalitis patients. Annals of Clinical and Translational Neurology. 2019;6(5):945–953. https://doi.org/10.1002/acn3.740Räuber S., Heming M., Repple J., Ruland T., Kuelby R., SchulteMecklenbeck A. et al. Cerebrospinal fl uid fl ow cytometry distinguishes psychosis spectrum disorders from diff erential diagnoses. Molecular Psychiatry. 2021;November:1–10. https://doi.org/10.1038/s41380-021-01244-5Räuber S., Heming M., Repple J., Ruland T., Kuelby R., SchulteMecklenbeck A. et al. Cerebrospinal fl uid fl ow cytometry distinguishes psychosis spectrum disorders from diff erential diagnoses. Molecular Psychiatry. 2021;November:1–10. https://doi.org/10.1038/s41380-021-01244-5Wilke J.B.H., Hindermann M., Berghoff S. A., Zihsler S., Arinrad S., Ronnenberg A. et al. Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis. Molecular Psychiatry. 2021;26:7746–7759. https://doi.org/10.1038/s41380-021-01238-3Wilke J.B.H., Hindermann M., Berghoff S. A., Zihsler S., Arinrad S., Ronnenberg A. et al. Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis. Molecular Psychiatry. 2021;26:7746–7759. https://doi.org/10.1038/s41380-021-01238-3Jurek B., Chayka M., Kreye J., Lang K., Kraus L., Fidzinski P. et al. Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function. Annals of Neurology. 2019;86(5):656–670. https://doi.org/10.1002/ana.25552Jurek B., Chayka M., Kreye J., Lang K., Kraus L., Fidzinski P. et al. Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function. Annals of Neurology. 2019;86(5):656–670. https://doi.org/10.1002/ana.25552Pröbstel A.K., Zamvil S.S. Do maternal anti–N-methyl-D-aspartate receptor antibodies promote development of neuropsychiatric disease in children? Annals of Neurology. 2019;86(5):653–655. https://doi.org/10.1002/ana.25584Pröbstel A.K., Zamvil S.S. Do maternal anti–N-methyl-D-aspartate receptor antibodies promote development of neuropsychiatric disease in children? Annals of Neurology. 2019;86(5):653–655. https://doi.org/10.1002/ana.25584Gresa-Arribas N., Titulaer M. J., Torrents A., Aguilar E., McCracken L., Leypoldt F. et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. The Lancet Neurology. 2014;13(2):167–177.https://doi.org/https://doi.org/10.1016/S1474-4422(13)70282-5Gresa-Arribas N., Titulaer M. J., Torrents A., Aguilar E., McCracken L., Leypoldt F. et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. The Lancet Neurology. 2014;13(2):167–177.https://doi.org/https://doi.org/10.1016/S1474-4422(13)70282-5Herken J., Prüss H. Red fl ags: Clinical signs for identifying autoimmune encephalitis in psychiatric patients. Frontiers in Psychiatry. 2017;8(FEB):1–9. https://doi.org/10.3389/fpsyt.2017.00025Herken J., Prüss H. Red fl ags: Clinical signs for identifying autoimmune encephalitis in psychiatric patients. Frontiers in Psychiatry. 2017;8(FEB):1–9. https://doi.org/10.3389/fpsyt.2017.00025Scott J.G., Gillis D., Swayne A., Blum S. Testing for antibodies to N-methyl-d-aspartate receptor and other neuronal cell surface antigens in patients with early psychosis. Australian and New Zealand Journal of Psychiatry. 2018;52(8):727–729. https://doi.org/10.1177/0004867418782421Scott J.G., Gillis D., Swayne A., Blum S. Testing for antibodies to N-methyl-d-aspartate receptor and other neuronal cell surface antigens in patients with early psychosis. Australian and New Zealand Journal of Psychiatry. 2018;52(8):727–729. https://doi.org/10.1177/0004867418782421Engen K., Wortinger L.A., Jorgensen K.N., Lundberg M., Bohman H., Smelror R.E. et al. Autoantibodies to the N-MethylD-Aspartate Receptor in Adolescents with Early Onset Psychosis and Healthy Controls. MedRxiv. 2020;01.06.20016626. https://doi.org/10.1101/2020.01.06.20016626Engen K., Wortinger L.A., Jorgensen K.N., Lundberg M., Bohman H., Smelror R.E. et al. Autoantibodies to the N-MethylD-Aspartate Receptor in Adolescents with Early Onset Psychosis and Healthy Controls. MedRxiv. 2020;01.06.20016626. https://doi.org/10.1101/2020.01.06.20016626Warren N., Swayne A., Siskind D., O’gorman C., Prain K., Gillis D., Blum S. Serum and CSF anti-nmdar antibody testing in psychiatry. Journal of Neuropsychiatry and Clinical Neurosciences. 2020;32(2):154–160. https://doi.org/10.1176/appi.neuropsych.19030079Warren N., Swayne A., Siskind D., O’gorman C., Prain K., Gillis D., Blum S. Serum and CSF anti-nmdar antibody testing in psychiatry. Journal of Neuropsychiatry and Clinical Neurosciences. 2020;32(2):154–160. https://doi.org/10.1176/appi.neuropsych.19030079Warren N., Flavell J., O’Gorman , C., Swayne A., Blum S., Kisely S., Siskind D. Screening for anti-NMDAR encephalitis in psychiatry. Journal of Psychiatric Research. 2020;125(March):28–32. https://doi.org/10.1016/j.jpsychires.2020.03.007Warren N., Flavell J., O’Gorman , C., Swayne A., Blum S., Kisely S., Siskind D. Screening for anti-NMDAR encephalitis in psychiatry. Journal of Psychiatric Research. 2020;125(March):28–32. https://doi.org/10.1016/j.jpsychires.2020.03.007Espinola-Nadurille M., Flores-Rivera J., Rivas-Alonso V., Vargas-Cañas S., Fricchione G.L., Bayliss L., et al. Catatonia in patients with anti-NMDA receptor encephalitis. Psychiatry and Clinical Neurosciences. 2019;73(9):574–580. https://doi.org/10.1111/pcn.12867Espinola-Nadurille M., Flores-Rivera J., Rivas-Alonso V., Vargas-Cañas S., Fricchione G.L., Bayliss L., et al. Catatonia in patients with anti-NMDA receptor encephalitis. Psychiatry and Clinical Neurosciences. 2019;73(9):574–580. https://doi.org/10.1111/pcn.12867Marques Macedo I., Gama Marques J. Catatonia secondary to anti-N-methyl-D-aspartate receptor (NMDAr) encephalitis: a review. CNS Spectrums. 2019;1–18. https://doi.org/10.1017/s1092852919001573Marques Macedo I., Gama Marques J. Catatonia secondary to anti-N-methyl-D-aspartate receptor (NMDAr) encephalitis: a review. CNS Spectrums. 2019;1–18. https://doi.org/10.1017/s1092852919001573DeSena A.D., Greenberg B.M., Graves D. Three Phenotypes of Anti–N-Methyl-d-Aspartate Receptor Antibody Encephalitis in Children: Prevalence of Symptoms and Prognosis. Pediatric Neurology. 2014;51(4):542–549. https://doi.org/https://doi.org/10.1016/j.pediatrneurol.2014.04.030DeSena A.D., Greenberg B.M., Graves D. Three Phenotypes of Anti–N-Methyl-d-Aspartate Receptor Antibody Encephalitis in Children: Prevalence of Symptoms and Prognosis. Pediatric Neurology. 2014;51(4):542–549. https://doi.org/https://doi.org/10.1016/j.pediatrneurol.2014.04.030Ludwig R.J., Vanhoorelbeke K., Leypoldt F., Kaya Z., Bieber K., McLachlan S.M. et al. Mechanisms of autoantibody-induced pathology. Frontiers in Immunology. 2017;8(05). https://doi.org/10.3389/fi mmu.2017.00603Ludwig R.J., Vanhoorelbeke K., Leypoldt F., Kaya Z., Bieber K., McLachlan S.M. et al. Mechanisms of autoantibody-induced pathology. Frontiers in Immunology. 2017;8(05). https://doi.org/10.3389/fi mmu.2017.00603Day G.S., High S.M., Cot B., Tang-Wai D.F. Anti-NMDA-receptor encephalitis: case report and literature review of an underrecognized condition. Journal of General Internal Medicine. 2011;26(7):811–816. https://doi.org/10.1007/s11606-011-1641-9Day G.S., High S.M., Cot B., Tang-Wai D.F. Anti-NMDA-receptor encephalitis: case report and literature review of an underrecognized condition. Journal of General Internal Medicine. 2011;26(7):811–816. https://doi.org/10.1007/s11606-011-1641-9Graus F., Dalmau J. Paraneoplastic neurological syndromes. Curr Opin Neurol. 2012;25(6):795–801. https://doi.org/ 10.1097/WCO.0b013e328359da15Graus F., Dalmau J. Paraneoplastic neurological syndromes. Curr Opin Neurol. 2012;25(6):795–801. https://doi.org/ 10.1097/WCO.0b013e328359da15Graus F., Vogrig A., Muñiz-Castrillo S., Antoine J. C. G., Desestret V., Dubey D. et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurology(R) Neuroimmunology & Neuroin fl ammation 2021;8(4):e1014. https://doi.org/10.1212/NXI.0000000000001014Graus F., Vogrig A., Muñiz-Castrillo S., Antoine J. C. G., Desestret V., Dubey D. et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurology(R) Neuroimmunology & Neuroin fl ammation 2021;8(4):e1014. https://doi.org/10.1212/NXI.0000000000001014

The authors declare that there are no conflicts of interest present.